Table 3. Number of patients with adjudicated clinical events.
Adjudicated clinical event | Febuxostat (n = 241) | Control (n = 247) |
---|---|---|
Total, number (%) | 9 (3.7) | 16 (6.5) |
Cardiovascular death | 1 (0.4) | 3 (1.2) |
Nonfatal myocardial infarction | 0 (0.0) | 1 (0.4) |
Nonfatal stroke | 3 (1.2) | 5 (2.0) |
Composite renal eventsa | 3 (1.2) | 4 (1.6) |
Non-cardiovascular death | 2 (0.8) | 4 (1.6) |
All-cause death | 3 (1.2) | 7 (2.8) |
aComposite of doubling of serum creatinine, initiation of hemodialysis, and renal transplantation.